Neuropsychological correlates of whole brain atrophy in Alzheimer's disease

Neuropsychologia

Volumn 46, Issue 6, 2008, Pages 1732-1737

  Schott, J M ^a   Crutch, S J ^a   Frost, C ^a,b   Warrington, E K ^a   Rossor, M N ^a   Fox, N C ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Alzheimer's disease; Atrophy; Clinical trials; Correlation; Neuropsychometry

Indexed keywords

ADULT; ALZHEIMER DISEASE; APTITUDE TEST; ARITHMETIC; ARTICLE; BRAIN ATROPHY; BRAIN CORTEX; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; FALLING; FEMALE; HUMAN; LINGUISTICS; MALE; METHODOLOGY; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCEPTION; SPATIAL MEMORY; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; THINKING; VERBAL MEMORY; VISUAL MEMORY;

AGED; ALZHEIMER DISEASE; ATROPHY; BRAIN; BRAIN MAPPING; DISEASE PROGRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; STATISTICS AS TOPIC;

EID: 43849112635     PISSN: 00283932     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropsychologia.2008.02.015     Document Type: Article

References (32)

1. Bland J.M., and Altman D.G. Statistic notes: Regression towards the mean. BMJ 308 (1994) 1499
2. Braak H., and Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica (Berlin) 82 (1991) 239-259
3. Chan D., Janssen J.C., Whitwell J.L., Watt H.C., Jenkins R., Frost C., et al. Rates of cerebral atrophy in early onset Alzheimer's disease increase with disease severity: A longitudinal MRI study. Lancet 362 (2003) 1121-1122
4. Clark C.M., Sheppard L., Fillenbaum G.G., Galasko D., Morris J.C., Koss E., et al. Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: A clinical perspective of data from the Consortium to Establish a Registry for Alzheimer's Disease. Archives of Neurology 56 (1999) 857-862
5. Clegg F., and Warrington E.K. Four easy memory tests for older adults. Memory 2 (1994) 167-182
6. Fox N.C., Black R.S., Gilman S., Rossor M.N., Griffith S.G., Jenkins L., et al. Effects of A{beta} immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease. Neurology 64 (2005) 1563-1572
7. Fox N.C., Freeborough P.A., and Rossor M.N. Visualisation and quantification of rates of atrophy in Alzheimer's disease. Lancet 348 (1996) 94-97
8. Fox N.C., Scahill R.I., Crum W.R., and Rossor M.N. Correlation between rates of brain atrophy and cognitive decline in AD. Neurology 52 (1999) 1687-1689
9. Freeborough P.A., and Fox N.C. The boundary shift integral: An accurate and robust measure of cerebral volume changes from registered repeat MRI. IEEE Transactions on Medical Imaging 16 (1997) 623-629
10. Freeborough P.A., Fox N.C., and Kitney R.I. Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans. Computer Methods and Programs in Biomedicine 53 (1997) 15-25
11. Freeborough P.A., Woods R.P., and Fox N.C. Accurate registration of serial 3D MR brain images and its application to visualizing change in neurodegenerative disorders. Journal of Computer Assisted Tomography 20 (1996) 1012-1022
12. Frost C., Kenward M.G., and Fox N.C. The analysis of repeated 'direct' measures of change illustrated with an application in longitudinal imaging. Statistics in Medicine 23 (2004) 3275-3286
13. Galasko D.R., Gould R.L., Abramson I.S., and Salmon D.P. Measuring cognitive change in a cohort of patients with Alzheimer's disease. Statistics in Medicine 19 (2000) 1421-1432
14. Jack C.R., Petersen R.C., Xu Y.C., Waring S.C., O'Brien P.C., Tangalos E.G., et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 49 (1997) 786-794
15. Jack C.R., Shiung M.M., Gunter J.L., O'Brien P.C., Weigand S.D., Knopman D.S., et al. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 62 (2004) 591-600
16. Jack C.R., Slomkowski M., Gracon S., Hoover T.M., Felmlee J.P., Stewart K., et al. MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD. Neurology 60 (2003) 253-260
17. Jackson M., and Warrington E.K. Arithmetic skills in patients with unilateral cerebral lesions. Cortex 22 (1986) 611-620
18. Kaye J.A. Methods for discerning disease-modifying effects in Alzheimer disease treatment trials. Archives of Neurology 57 (2000) 312-314
19. Leber P. Guidelines for the clinical evaluation of antidementia drugs: First draft (1990), Division of Neuropharmacological Drug Products, Food and Drugs Administration, Rockville, MD
20. Mani R.B. The evaluation of disease modifying therapies in Alzheimer's disease: A regulatory viewpoint. Statistics in Medicine 23 (2004) 305-314
21. McKenna P., and Warrington E.K. The graded naming test (1983), NFER-Nelson, Windsor, UK
22. Mouton P.R., Martin L.J., Calhoun M.E., Dal Forno G., and Price D.L. Cognitive decline strongly correlates with cortical atrophy in Alzheimer's dementia. Neurobiology of Aging 19 (1998) 371-377
23. Murphy D.G., DeCarli C.D., Daly E., Gillette J.A., McIntosh A.R., Haxby J.V., et al. Volumetric magnetic resonance imaging in men with dementia of the Alzheimer type: Correlations with disease severity. Biological Psychiatry 34 (1993) 612-621
24. Nelson H. The National Adult Reading Test (NART): Test manual (1982), The NFER-NELSON Publishing Company Ltd., Windsor
25. Newman S.K., Warrington E.K., Kennedy A.M., and Rossor M.N. The earliest cognitive change in a person with familial Alzheimer's disease: Presymptomatic neuropsychological features in a pedigree with familial Alzheimer's disease confirmed at necropsy. Journal of Neurology and Neurosurgery Psychiatry 57 (1994) 967-972
26. Schott J.M., Fox N.C., Frost C., Scahill R.I., Janssen J.C., Chan D., et al. Assessing the onset of structural change in familial Alzheimer's disease. Annals of Neurology 53 (2003) 181-188
27. Schott J.M., Frost C., Whitwell J.L., MacManus D.G., Boyes R.G., Rossor M.N., et al. Combining short interval MRI in Alzheimer's disease: Implications for therapeutic trials. Journal of Neurology 253 (2006) 1147-1153
28. Silbert L.C., Quinn J.F., Moore M.M., Corbridge E., Ball M.J., Murdoch G., et al. Changes in premorbid brain volume predict Alzheimer's disease pathology. Neurology 61 (2003) 487-492
29. Sled J.G., Zijdenbos A.P., and Evans A.C. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Transactions on Medical Imaging 17 (1998) 87-97
30. Smith A.D., and Jobst K.A. Use of structural imaging to study the progression of Alzheimer's disease. British Medical Bulletin 52 (1996) 575-586
31. Warrington E.K., and James M. The visual object and space perception battery (1991), Thames Valley Test Co, Bury St Edmunds
32. Wechsler D. The Wechsler abbreviated scale of intelligence (1999), The Psychological Corporation, San Antonio, TX